Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,390.00    0.00 (0.00%)
Bid:
2,000.00
Ask:
2,450.00
Spread: 450.00 (22.50%)
Market Cap: £7.67b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Acquisition

20 Dec 2022 07:00

RNS Number : 2386K
Bunzl PLC
20 December 2022
 

20 December 2022

 

BUNZL ANNOUNCEMENT REGARDING ACQUISITIONS AND DISPOSAL

 

Bunzl plc, the specialist international distribution and services Group, today announces that it has signed agreements to acquire four businesses and agreed to the sale of its UK healthcare division. Together, these transactions are expected to be profit neutral to the Group and will generate a small cash inflow. They reflect Bunzl's ongoing discipline around returns focused capital allocation and portfolio optimisation.

 

The Group has agreed to the sale of its UK healthcare division to Mediq. In 2021, the UK healthcare division generated £216 million of revenue.

 

The Group remains focused on expanding its specialist healthcare business and in November completed the acquisition of Toomac Ophthalmic & Solutions, a distributor of ophthalmology products in New Zealand. In the 12 months to March 2022 the business generated revenue of NZD 11 million (c.£6 million). In October, Bunzl also signed an agreement to acquire GRC, an exclusive distributor of innovative medical technology devices in Australia with revenue of AUD 4 million (c.£3 million) in the 12 months to June 2022. Both businesses specialise in surgical products and broaden the offering in Bunzl's healthcare business in the region, which has expanded significantly over the last two years.

 

In October, Bunzl also completed the acquisition of VM Footwear, a distributor of Personal Protection Equipment based in Czech Republic, specialising in own brand footwear throughout Central Eastern Europe and providing an entry into this category in the region. In the year to June 2022 the business generated CZK 366 million (c.£13 million) of revenue.

 

Furthermore, in November Bunzl completed the acquisition of PM Pack, a distributor of packaging products in Denmark, mainly focused on food processor customers. The acquisition strengthens the Group's foodservice offering in Denmark and in the year to September 2022 the business generated revenue of DKK 142 million (c.£16 million). 

 

Frank van Zanten, Chief Executive Officer of Bunzl, said:

 

"Today's announcement reflects Bunzl's commitment to optimal capital allocation across the Group. The announced acquisitions are highly complementary, expand our product offering in each country, and all achieve double digit margins, with their profits offsetting the expected profit contribution from the announced disposal. I would like to offer a warm welcome to all the teams from the newly acquired businesses to the Bunzl family.

 

I want to thank our departing colleagues for all the contributions they made as part of Bunzl, particularly most recently for their incredible dedication to supporting customers during the pandemic. I wish the whole team the very best for the future."

 

 

Enquiries:

 

Bunzl plc

Frank van Zanten, Chief Executive Officer

Richard Howes, Chief Financial Officer

Sunita Entwisle, Head of Investor Relations

Tel: +44 (0)20 7725 5000

Tulchan

Martin Robinson

Olivia Peters

Tel: +44 (0)20 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQTLBLTMTABBTT
Date   Source Headline
3rd Jun 202610:45 amRNSDirector/PDMR Shareholding
1st Jun 202610:15 amRNSTotal Voting Rights
1st Jun 202610:00 amRNSAdmission to Trading
8th May 20264:13 pmRNSDirector/PDMR Shareholding
7th May 20262:43 pmRNSDirector/PDMR Shareholding
6th May 202610:05 amRNSDirector/PDMR Shareholding
1st May 202611:15 amRNSTotal Voting Rights
22nd Apr 20264:15 pmRNSResult of AGM
22nd Apr 20267:00 amRNSTrading Statement
13th Apr 20264:00 pmRNSDirector/PDMR Shareholding
9th Apr 202612:01 pmRNSDirector/PDMR Shareholding
1st Apr 20264:00 pmRNSDirector/PDMR Shareholding
1st Apr 202611:00 amRNSTotal Voting Rights
31st Mar 20264:50 pmRNSDirector/PDMR Shareholding
20th Mar 20262:28 pmRNSDirector/PDMR Shareholding
18th Mar 20265:26 pmRNSDirector/PDMR Shareholding
17th Mar 20264:20 pmRNSAnnual Financial Report
16th Mar 20263:00 pmRNSDirector/PDMR Shareholding
16th Mar 20263:00 pmRNSDirector/PDMR Shareholding
11th Mar 20264:00 pmRNSDirector/PDMR Shareholding
11th Mar 20264:00 pmRNSDirector/PDMR Shareholding
10th Mar 20263:30 pmRNSDirector Declaration
10th Mar 20263:30 pmRNSDirector Declaration
9th Mar 202610:20 amRNSDirector/PDMR Shareholding
5th Mar 20265:15 pmRNSDirector/PDMR Shareholding
4th Mar 20264:00 pmRNSDirector/PDMR Shareholding
3rd Mar 20264:45 pmRNSDirector/PDMR Shareholding
2nd Mar 202611:00 amRNSTotal Voting Rights
2nd Mar 202610:00 amRNSDividend Declaration
2nd Mar 20267:00 amRNSFinal Results
3rd Feb 20265:00 pmRNSDirector/PDMR Shareholding
2nd Feb 202612:45 pmRNSTotal Voting Rights
13th Jan 20265:00 pmRNSDirector/PDMR Shareholding
7th Jan 20265:15 pmRNSDirector/PDMR Shareholding
6th Jan 202611:15 amRNSDirector/PDMR Shareholding
2nd Jan 202610:45 amRNSTotal Voting Rights
17th Dec 20257:00 amRNSTrading Statement
3rd Dec 202512:00 pmRNSDirector/PDMR Shareholding
1st Dec 202511:00 amRNSTotal Voting Rights
27th Nov 20259:00 amRNSAdditional Listing
26th Nov 20253:34 pmRNSPublication of Admission Particulars.
21st Nov 20255:30 pmRNSHolding(s) in Company
17th Nov 20255:34 pmRNSHolding(s) in Company
13th Nov 20259:00 amRNSAdditional Listing
5th Nov 20259:45 amRNSDirector/PDMR Shareholding
3rd Nov 20254:00 pmRNSHolding(s) in Company
3rd Nov 20253:29 pmRNSTotal Voting Rights
3rd Nov 20259:30 amRNSBlock listing Interim Review
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.